Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Decision making under uncertainty, therapeutic inertia, and physicians' risk preferences in the management of multiple sclerosis (DIScUTIR MS).
Efficacy and Safety of Fingolimod in Hispanic Patients with Multiple Sclerosis: Pooled Clinical Trial Analyses.
Interrater Reliability of Four Sensory Measures in People with Multiple Sclerosis.
Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study.
Effect of vitamin D on MS activity by disease-modifying therapy class.
Daclizumab in multiple sclerosis: a high-yield extension study.
The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis.
Tumor necrosis factor-α impairs oligodendroglial differentiation through a mitochondria-dependent process.
CombiRx for MS not better than monotherapy
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.
Fumaric acid esters prevent the NLRP3 inflammasome-mediated and ATP-triggered pyroptosis of differentiated THP-1 cells.
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.
Eosinophilic Fasciitis-like Disorder Developing in the Setting of Multiple Sclerosis Therapy.
Multimodal quantitative MRI assessment of cortical damage in relapsing-remitting multiple sclerosis.
Hypovitaminosis D upscales B-cell immunoreactivity in multiple sclerosis.
The value of qualitative and quantitative assessment of lesion to cerebral cortex signal ratio on double inversion recovery sequence in the differentiation of demyelinating plaques from non-specific T2 hyperintensities.
The immunosuppressant leflunomide inhibits lymphocyte proliferation by inhibiting pyrimidine biosynthesis.
Clarity Extension Study
12-oxo-phytodienoic acid, a plant-derived oxylipin, attenuates lipopolysaccharide-induced inflammation in microglia.
A validated gene regulatory network and GWAS identifies early regulators of T cell-associated diseases.
Genzyme receives positive CHMP opinion for LEMTRADA™ (alemtuzumab) in Europe
Assessment of structural and functıonal vısual outcomes ın relapsıng remıttıng multıple sclerosıs wıth vısual evoked potentıals and optıcal coherence tomography.
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells.
A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosis.
Myelin Basic Protein Citrullination in Multiple Sclerosis: A Potential Therapeutic Target for the Pathology.

Pages